Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in systemic lupus erythematosus.
News-Medical.Net on MSN
IV iron dextran more cost-effective than oral iron for women with heavy menstrual bleeding and IDA
A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback